Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,965.00
Bid: 1,968.00
Ask: 1,970.00
Change: 7.00 (0.36%)
Spread: 2.00 (0.102%)
Open: 1,977.00
High: 1,980.00
Low: 1,957.00
Prev. Close: 1,958.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Carillion Finance Director lowers holding

Fri, 08th Nov 2013 16:03

Carillion's Group Finance Director, Richard Adam, on Thursday sold, on behalf of his wife, 40,000 shares. Each of these was sold for 309.04p, for a total trade value of £123,616. Adam's stake now stands at 118,238 shares. The disposal was made a week after the support services company announced that it had bagged £180m-worth of highway contracts in recent weeks, including a £70m deal to upgrade another section of the M6.Under the contract, the FTSE 250 group will transform the M6 between junctions 10A and 13 in the West Midlands into a so-called smart motorway which use a range of technologies and new operating procedures to control the flow of traffic. The firm is also part of a joint venture that has been picked by Stockport Metropolitan Borough Council as the preferred bidder to design and build the A6 Manchester Airport Relief Road. It said its share of the £100m contract would be some £50m. In addition, Carillion was awarded a clutch of smaller contracts including a 12-month contract for Northumberland County Council to build the £25m Morpeth Northern bypass and a £16m 20-month contract for Leeds City Council for the maintenance of the A58 Woodhouse Tunnel.Top Director BuysHydroDec Group (HYR) Director name: Mr Andrew BlackAmount purchased: 89,777,776 @ 11.25p Value: £10,100,000HydroDec Group (HYR) Director name: Lord Colin MoynihanAmount purchased: 2,666,667 @ 11.25p Value: £300,000Telecity Group (TCY) Director name: Ms Claudia Arney Amount purchased: 7,000 @ 674.50p Value: £47,215Camco Clean Energy (CCE) Director name: Mr Jonathan Anthony Frank MarrenAmount purchased: 306,907 @ 6.50p Value: £19,949Ruffer Investment Company Ltd Red PTG Pref Shares (RICA) Director name: Mr Ashe WindhamAmount purchased: 5,000 @ 220.65p Value: £11,032Top Director SellsTate & Lyle (TATE) Director name: Mr Tim LodgeAmount sold: 105,358 @ 788.00p Value: £830,221Hikma Pharmaceuticals (HIK) Director name: Mr Khalid NabilsiAmount sold: 49,000 @ 1,195.00p Value: £585,550Tate & Lyle (TATE) Director name: Mr Tim LodgeAmount sold: 71,690 @ 788.00p Value: £564,917Tate & Lyle (TATE) Director name: Mr Tim LodgeAmount sold: 24,377 @ 788.00p Value: £192,091Carillion (CLLN) Director name: Mr Richard AdamAmount sold: 40,000 @ 309.04p Value: £123,616Mondi (MNDI) Director name: Mr Peter OswaldAmount sold: 10,000 @ 1,015.00p Value: £101,500Tate & Lyle (TATE) Director name: Mr Tim LodgeAmount sold: 12,305 @ 788.00p Value: £96,963Mondi (MNDI) Director name: Mr Peter OswaldAmount sold: 6,506 @ 1,013.00p Value: £65,906Lancashire Holdings Limited (LRE) Director name: Mr John Henry BishopAmount sold: 4,807 @ 804.99p Value: £38,696Mondi (MNDI) Director name: Mr Peter OswaldAmount sold: 3,494 @ 1,014.00p Value: £35,429NR
More News
24 Feb 2022 10:31

TOP NEWS: Hikma Pharmaceutical records revenue growth and lifts payout

(Alliance News) - Hikma Pharmaceutical PLC on Thursday reported full-year revenue growth on a "strong" performance by its three business segments and lifted its shareholder payout.

Read more
24 Feb 2022 07:58

Hikma Pharmaceutical delivers year of 'solid growth' and 'strategic momentum'

(Sharecast News) - Drugmaker Hikma Pharmaceutical said on Thursday that it had delivered another successful year of "solid growth and continued strategic momentum", with both revenue and operating profits improving year-on-year.

Read more
24 Feb 2022 07:50

LONDON MARKET PRE-OPEN: Share buybacks for Lloyds Banking and Hikma

(Alliance News) - Stock prices in London are seen opening sharply lower, with the FTSE 100 called down almost 200 points, amid fear of a full-scale war in eastern Europe after Russia announced the beginning of a military operation in Ukraine.

Read more
17 Feb 2022 16:08

UK earnings, trading statements calendar - next 7 days

Friday 18 February  
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 21 February 
Bank of Cyprus Holdings PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Tristel PLCTrading Statement
Wilmington PLCHalf Year Results
Tuesday 22 February 
Antofagasta PLCFull Year Results
Bank of Georgia Group PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Blancco Technology Group PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Coca-Cola HBC AGFull Year Results
Hargreaves Lansdown PLCHalf Year Results
HSBC Holdings PLCFull Year Results (at 0400 GMT)
InterContinental Hotels Group PLCFull Year Results
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Synectics PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wednesday 23 February 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Barclays PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
CAP-XX LtdHalf Year Results
Georgia Capital PLCFull Year Results
International Personal Finance PLCFull Year Results
Irish Residential Properties REIT PLCFull Year Results
Metro Bank PLCFull Year Results
Hochschild Mining PLCFull Year Results
Photo-Me International PLCFull Year Results
Rio Tinto PLCFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Ted Baker PLCTrading Statement
Unite Group PLCFull Year Results
Thursday 24 February 
Anglo American PLCFull Year Results
BAE Systems PLCFull Year Results
Centrica PLCFull Year Results
Conduit Holdings LtdFull Year Results
Derwent London PLCFull Year Results
Drax Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Inchcape PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Rathbone Group PLCFull Year Results
Ricardo PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
St James's Place PLCFull Year Results
Tremor International LtdFull Year Results
WPP PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.